NCT06529042View on ClinicalTrials.gov

SCRIPT: Sickle Cell Risk in Pregnancy Tool

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Sickle Cell DiseasePregnancy, High RiskPregnancy Complications
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (3)

21218

Johns Hopkins University, Baltimore

V5Z 1M9

Providence Health Care, Vancouver

H2X 0C1

Centre hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

collaborator

St. Paul's Hospital, Vancouver (Providence Health Care)

UNKNOWN

lead

Mount Sinai Hospital, Canada

OTHER